CoChat

Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer

Open access
Kasprzak, Aldona · 2021 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 278 of the 284 references it cites were found in a registry or an index.

Abstract

Colorectal cancer (CRC) is one of the most common aggressive carcinoma types worldwide, characterized by unfavorable curative effect and poor prognosis. Epidemiological data re-vealed that CRC risk is increased in patients with metabolic syndrome (MetS) and its serum components (e.g., hyperglycemia). High glycemic index diets, which chronically raise post-prandial blood glucose, may at least in part increase colon cancer risk via the insulin/insulin-like growth factor 1 (IGF-1) signaling pathway. However, the underlying mechanisms linking IGF-1 and MetS are still poorly understood. Hyperactivated glucose uptake and aerobic glycolysis (the Warburg effect) are considered as a one of six hallmarks of cancer, including CRC. However, the role of insulin/IGF-1 signaling during the acquisition of the Warburg metabolic phenotypes by CRC cells is still poorly understood. It most likely results from the interaction of multiple processes, directly or indirectly regulated by IGF-1, such as activation of PI3K/Akt/mTORC, and Raf/MAPK signaling pathways, activation of glucose transporters (e.g., GLUT1), activation of key glycolytic enzymes (e.g., LDHA, LDH5, HK II, and PFKFB3), aberrant expression of the oncogenes (e.g., MYC, and KRAS) and/or overexpression of signaling proteins (e.g., HIF-1, TGF-β1, PI3K, ERK, Akt, and mTOR). This review describes the role of IGF-1 in glucose metabolism in physiology and colorectal carcinogenesis, including the role of the insulin/IGF system in the Warburg effect. Furthermore, current therapeutic strategies aimed at repairing impaired glucose metabolism in CRC are indicated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22126434

Cites

278 of 278 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic illustration of the insulin/IGF-1 system involved in the development and progression of colorectal cancer (CRC) through direct (mitotic effects) and indirect (aerobic glycolysis) activity. [↑,↓-increase (up-regulation)/decrease (down-regulation) expression/level; AMPK-adenosine monophosphate (AMP)-activated protein kinase; CRNDE-colorectal neoplasia differentially expressed gene; GLUT-glucose transporter; GH-R-growth hormone receptor; GRP78-glucose-regulated protein 78; HIF-1α, -β-hypoxia-inducible transcription factor-1α, -β; HK II-hexokinase II; IGF-1-insulin-like growth factor 1; IGFBP-1;-2-IGF binding proteins 1,-2; JAK/STAT3-Janus kinase/signal transducer and activator of transcription; KLK10-kallikrein-related peptidase; LDHA, -5-lactate dehydrogenase A, -5; mKRAS-mutant KRAS gene; mMYC-mutant MYC gene; mTP53-mutant tumor protein 53 gene; PI3K/Akt/mTOR-phosphatidylinositol 3 kinase/Akt/mammalian target of rapamycin complex; WAT-white adipose tissue].
Figure 1 Schematic illustration of the insulin/IGF-1 system involved in the development and progression of colorectal cancer (CRC) through direct (mitotic effects) and indirect (aerobic glycolysis) activity. [↑,↓-increase (up-regulation)/decrease (down-regulation) expression/level; AMPK-adenosine monophosphate (AMP)-activated protein kinase; CRNDE-colorectal neoplasia differentially expressed gene; GLUT-glucose transporter; GH-R-growth hormone receptor; GRP78-glucose-regulated protein 78; HIF-1α, -β-hypoxia-inducible transcription factor-1α, -β; HK II-hexokinase II; IGF-1-insulin-like growth factor 1; IGFBP-1;-2-IGF binding proteins 1,-2; JAK/STAT3-Janus kinase/signal transducer and activator of transcription; KLK10-kallikrein-related peptidase; LDHA, -5-lactate dehydrogenase A, -5; mKRAS-mutant KRAS gene; mMYC-mutant MYC gene; mTP53-mutant tumor protein 53 gene; PI3K/Akt/mTOR-phosphatidylinositol 3 kinase/Akt/mammalian target of rapamycin complex; WAT-white adipose tissue].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Cited by

See all 255

Metadata

Authors
Kasprzak, A.
Affiliations
Poznan University of Medical Sciences (PL)
Corresponding author
Kasprzak, Aldona
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-06-16
Volume
22
Issue
12
Pages
6434
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3169775278
Cited by
248
References
284
Citations by year
2026: 51 · 2025: 73 · 2024: 60 · 2023: 32 · 2022: 22 · 2021: 10
FWCI
5.03
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords
insulin-like growth factor I, colorectal cancer, glucose metabolism, Warburg effect, aerobic glycolysis, metabolic syndrome, hyperglycemia, PI3K/AKT/mTOR pathway, glucose transporters, GLUT1, glycolytic enzymes, c-Myc, KRAS, HIF-1, TGF-β1, colorectal carcinogenesis
MeSH terms
Animals, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Disease Susceptibility, Glucose, Humans, Insulin-Like Growth Factor I, Metabolic Diseases, Risk Factors, Colorectal Neoplasms, Signal Transduction, Biomarkers, Gene Expression Regulation, Neoplastic, Carbohydrate Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.